Alzheon Announces Presentations At Two Upcoming Investor Conferences

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders, today announced that Martin Tolar, M.D., Ph.D., Founder, President and Chief Executive Officer, will be presenting a corporate overview and update at two upcoming investor conferences.

Help employers find you! Check out all the jobs and post your resume.

Back to news